Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Secondary prevention after ischemic stroke].

R W Baumgartner1, D Georgiadis

  • 1Neurologische Klinik, Universitätsspital Zürich, Schweiz. ralf.baumgartner@nos.usz.ch

Praxis
|March 20, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New ischaemic brain lesions in cervical artery dissection stratified to antiplatelets or anticoagulants.

European journal of neurology·2015
Same author

Relapsing depression in paramedian thalamic infarctions.

Behavioural neurology·2014
Same author

Zurich Fabry study - prevalence of Fabry disease in young patients with first cryptogenic ischaemic stroke or TIA.

European journal of neurology·2012
Same author

IV thrombolysis and statins.

Neurology·2011
Same author

Outcome of intravenous thrombolysis in stroke patients weighing over 100 kg.

Cerebrovascular diseases (Basel, Switzerland)·2011
Same author

Intravenous thrombolysis in patients with stroke attributable to small artery occlusion.

European journal of neurology·2010
Same journal

Praxis·2026
Same journal

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Praxis·2026
Same journal

[Laser interstitial thermotherapy (LITT): a minimally invasive neurosurgical treatment option for brain tumours and radiation necrosis].

Praxis·2026
Same journal

[Persistent back pain after lifting trauma. From the trivial to the rare case].

Praxis·2026
Same journal

[A patient with dizziness and gait instability - a diagnostic challenge].

Praxis·2026
Same journal

[Meningoencephalitis caused by listeria monocytogenes].

Praxis·2026
See all related articles

Secondary stroke prevention is achieved through managing vascular risk factors like hypertension and high cholesterol. Treatments include antihypertensives, statins, anticoagulation, and antiplatelet agents, with surgical options for carotid stenosis.

Area of Science:

  • Neurology
  • Cardiology
  • Vascular Surgery

Background:

  • Secondary stroke prevention is crucial for reducing recurrence.
  • Managing vascular risk factors plays a key role in stroke prevention.
  • Recent studies have highlighted the efficacy of specific therapies.

Purpose of the Study:

  • To review current strategies for secondary stroke prevention.
  • To discuss the role of risk factor modification, anticoagulation, and surgical interventions.
  • To present findings from key studies like PROGRESS and HPS.

Main Methods:

  • Review of published literature on secondary stroke prevention.
  • Analysis of data from the PROtection aGainst REcurrent Stroke Study (PROGRESS) and Heart Protection Study (HPS).

Related Experiment Videos

  • Evaluation of treatment guidelines for carotid stenosis, cardiac embolism, and antiplatelet therapy.

    • Main Results:

    • Antihypertensive therapy (perindoprile/indapamide) reduced stroke by 40% (PROGRESS).
    • Statin therapy reduced ischemic strokes by 20% in patients with elevated cholesterol (HPS).
    • Specific guidelines for carotid stenosis surgery, anticoagulation for cardiac embolism, and antiplatelet therapy (aspirin, clopidogrel) were outlined.

    Conclusions:

    • Antihypertensive and lipid-lowering therapies are effective in secondary stroke prevention.
    • Surgical and endovascular procedures are indicated for specific degrees of carotid stenosis.
    • Anticoagulation and antiplatelet agents are vital for preventing recurrent strokes from embolic or other causes.